Articular cartilage heterografts
AssigneeCrossCart, Inc.
InventorKevin R. Stone
Life of this patent
Estimating the term…
Loading patent…
AssigneeCrossCart, Inc.
InventorKevin R. Stone
Estimating the term…
The invention provides an article of manufacture comprising a substantially non-immunogenic articular cartilage heterograft for implantation into humans. The invention further provides a method for preparing an articular cartilage heterograft by removing at least a portion of an articular cartilage from a non-human animal to provide a heterograft; washing the heterograft in saline and alcohol; subjecting the heterograft to at least one treatment selected from the group consisting of exposure to ultraviolet radiation, immersion in alcohol, ozonation, freeze/thaw cycling, and optionally to chemical crosslinking. In accordance with the invention the heterograft has substantially the same mechanical properties as the native xenogeneic articular cartilage.
An article of manufacture comprising a substantially non-immunogenic glycosidase-treated articular cartilage heterograft for implantation into a human;
An article of manufacture comprising a substantially non-immunogenic glycosidase-treated articular cartilage heterograft for implantation into a human, produced by the process of
An articular cartilage heterograft for implantation into a human comprising
Dependencies are inferred from the claim text.